Envision Healthcare Corporation Increase (Decrease) in Accounts Receivable
Envision Healthcare Corporation reported Increase (Decrease) in Accounts Receivable of $48.80 million for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2018-08-07
- Envision Healthcare Corporation increase (decrease) in accounts receivable for the quarter ending 2018-06-30 was $8.30M, a 99.38% decline year-over-year.
- Envision Healthcare Corporation increase (decrease) in accounts receivable for the quarter ending 2018-03-31 was $40.50M, a 96.74% decline year-over-year.
- Envision Healthcare Corporation increase (decrease) in accounts receivable for the quarter ending 2017-12-31 was $1.44B, a 134.65% increase year-over-year.
- Envision Healthcare Corporation increase (decrease) in accounts receivable for the quarter ending 2017-09-30 was $1.43B, a 799.50% increase year-over-year.
- Envision Healthcare Corporation increase (decrease) in accounts receivable for fiscal 2017 was $5.46B, a 443.92% increase from fiscal 2016.
- Envision Healthcare Corporation increase (decrease) in accounts receivable for fiscal 2016 was $1.00B, a 207.48% increase from fiscal 2015.
- Envision Healthcare Corporation increase (decrease) in accounts receivable for fiscal 2015 was $326.20M, a 136.89% increase from fiscal 2014.
- Envision Healthcare Corporation increase (decrease) in accounts receivable for fiscal 2014 was $137.70M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2018-06-30 | $8.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $48.80M 10-Q · filed 2018-08-07 | $1.49B derived: sum of 3 quarters · filed 2018-08-07 | $2.93B derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | $40.50M 10-Q · filed 2018-05-10 | $1.48B derived: sum of 2 quarters · filed 2018-05-10 | $2.92B derived: sum of 3 quarters · filed 2018-05-10 | $4.25B derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-12-31 | $1.44B derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $2.88B derived: sum of 2 quarters · filed 2018-03-01 | $4.21B derived: sum of 3 quarters · filed 2018-08-07 | $5.46B 10-K · filed 2018-03-01 |
| 2017-09-30 | $1.43B derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $2.77B derived: sum of 2 quarters · filed 2018-08-07 | $4.01B 10-Q · filed 2017-11-03 | $4.63B derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-06-30 | $1.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.58B 10-Q · filed 2018-08-07 | $3.19B derived: sum of 3 quarters · filed 2018-08-07 | $3.35B derived: sum of 4 quarters · filed 2018-08-07 |
| 2017-03-31 | $1.24B 10-Q · filed 2018-05-10 | $1.86B derived: sum of 2 quarters · filed 2018-05-10 | $2.02B derived: sum of 3 quarters · filed 2018-05-10 | $2.13B derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $615.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $774.70M derived: sum of 2 quarters · filed 2018-03-01 | $888.50M derived: sum of 3 quarters · filed 2018-03-01 | $1.00B 10-K · filed 2018-03-01 |
| 2016-09-30 | $159.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $273.20M derived: sum of 2 quarters · filed 2017-11-03 | $387.70M 10-Q · filed 2017-11-03 | |
| 2016-06-30 | $113.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $228.30M 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $114.50M 10-Q · filed 2017-05-05 | |||
| 2015-12-31 | $326.20M 10-K · filed 2018-03-01 | |||
| 2014-12-31 | $137.70M 10-K · filed 2017-03-01 |